Doximity, Inc.

Name: Doximity, Inc. standardized financial statements, quarterly
Creator: Listed

DOCSNYSECIK 1516513TechnologyFiscal year ends Mar 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$156.6m, Q1 FY2027

Operating income$33.6m, Q1 FY2027

Net income$24.3m, Q1 FY2027

Doximity, Inc., income statement, quarterly
Line item	Unit	Q2 FY20242023-09-30	Q3 FY20242023-12-31	Q4 FY20242024-03-31	Q1 FY20252024-06-30	Q2 FY20252024-09-30	Q3 FY20252024-12-31	Q4 FY20252025-03-31	Q1 FY20262025-06-30	Q2 FY20262025-09-30	Q3 FY20262025-12-31	Q4 FY20262026-03-31	Q1 FY20272026-06-30
Revenue	$m	114	135	118	127	137	169	138	146	169	185	145	157
Cost of revenue	$m	12.8	12.2	12.6	13.6	13.7	14.2	14.5	15.8	16.4	18.7	19.4	23.7
Gross profit	$m	101	123	105	113	123	154	124	130	152	166	126	133
Research and development	$m	20.0	19.9	20.1	22.6	23.2	22.4	24.8	26.8	30.2	34.6	39.1	38.5
Operating income	$m	33.8	58.6	41.9	46.1	53.1	79.9	48.7	54.5	63.7	71.9	24.8	33.6
Income tax	$m	9.1	15.1	7.3	11.8	18.0	14.6	(4.1)	10.8	10.9	19.2	13.0	16.0
Net income	$m	30.6	48.0	40.6	41.4	44.2	75.2	62.5	53.3	62.1	61.6	19.1	24.3
Diluted EPS	$ per share	0.15	0.24	not reported	0.21	0.22	0.37	not reported	0.27	0.31	0.31	not reported	0.13
Basic EPS	$ per share	0.16	0.26	not reported	0.22	0.24	0.40	not reported	0.28	0.33	0.33	not reported	0.13

Balance sheet

Cash and equivalents$273.6m, Q1 FY2027

Shareholders' equity$916.1m, Q1 FY2027

Doximity, Inc., balance sheet, quarterly
Line item	Unit	Q2 FY20242023-09-30	Q3 FY20242023-12-31	FY20242024-03-31	Q1 FY20252024-06-30	Q2 FY20252024-09-30	Q3 FY20252024-12-31	FY20252025-03-31	Q1 FY20262025-06-30	Q2 FY20262025-09-30	Q3 FY20262025-12-31	FY20262026-03-31	Q1 FY20272026-06-30
Cash and equivalents	$m	108	123	96.8	111	184	165	210	137	169	64.8	219	274
Current assets	$m	863	841	913	908	958	1,013	1,089	1,034	1,092	993	944	914
Total assets	$m	1,026	1,001	1,079	1,073	1,119	1,172	1,264	1,204	1,257	1,157	1,124	1,084
Current liabilities	$m	123	105	147	135	132	116	156	160	140	150	155	150
Total liabilities	$m	154	136	178	160	157	141	182	179	162	178	173	168
Shareholders' equity	$m	871	865	901	914	961	1,031	1,083	1,026	1,096	979	951	916

Cash flow

Operating cash flow$42.0m, Q1 FY2027

Capital expenditure$62.0k, Q1 FY2027

Share repurchases$91.6m, Q1 FY2027

Doximity, Inc., cash flow, quarterly
Line item	Unit	Q2 FY20242023-09-30	Q3 FY20242023-12-31	Q4 FY20242024-03-31	Q1 FY20252024-06-30	Q2 FY20252024-09-30	Q3 FY20252024-12-31	Q4 FY20252025-03-31	Q1 FY20262025-06-30	Q2 FY20262025-09-30	Q3 FY20262025-12-31	Q4 FY20262026-03-31	Q1 FY20272026-06-30
Operating cash flow	$m	12.9	50.1	63.9	41.2	68.3	65.2	98.5	62.1	93.9	60.9	110	42.0
Capital expenditure	$m	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	not reported	not reported	not reported	0.1
Share repurchases	$m	164	76.8	17.7	51.2	23.0	19.3	26.8	122	21.9	197	90.5	91.6

Diluted shares (weighted)191.17m, Q1 FY2027

Doximity, Inc., shares, quarterly
Line item	Unit	Q2 FY20232022-09-30	Q3 FY20232022-12-31	Q1 FY20242023-06-30	Q2 FY20242023-09-30	Q3 FY20242023-12-31	Q1 FY20252024-06-30	Q2 FY20252024-09-30	Q3 FY20252024-12-31	Q1 FY20262025-06-30	Q2 FY20262025-09-30	Q3 FY20262025-12-31	Q1 FY20272026-06-30
Diluted shares (weighted)	m shares	214	212	212	209	200	199	200	202	201	201	199	191

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. Listed shows no prices and gives no investment advice.

Doximity, Inc.

Income statement

Balance sheet

Cash flow

Shares